957062-72-5 Usage
Uses
Used in Pharmaceutical Synthesis:
2-(Methoxycarbonyl)-4-pyridineboronic acid, pinacol ester is used as a reagent for the synthesis of phenylaminodiheteroarylpyrimidine derivatives and analogs, which are known for their antibacterial properties. 2-(Methoxycarbonyl)-4-pyridineboronic acid, pinacol ester plays a crucial role in the development of new and effective antibacterial agents to combat drug-resistant bacterial infections.
Used in Organic Chemistry Research:
In the field of organic chemistry, 2-(Methoxycarbonyl)-4-pyridineboronic acid, pinacol ester serves as a valuable intermediate for the synthesis of a wide range of organic compounds. Its unique structure allows for various chemical reactions, making it a useful building block for the creation of complex molecules and potential drug candidates.
Used in Material Science:
2-(Methoxycarbonyl)-4-pyridineboronic acid, pinacol ester's ability to form stable complexes with other molecules makes it a potential candidate for use in material science applications. It can be employed in the development of new materials with specific properties, such as improved conductivity, stability, or catalytic activity.
Check Digit Verification of cas no
The CAS Registry Mumber 957062-72-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,7,0,6 and 2 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 957062-72:
(8*9)+(7*5)+(6*7)+(5*0)+(4*6)+(3*2)+(2*7)+(1*2)=195
195 % 10 = 5
So 957062-72-5 is a valid CAS Registry Number.
957062-72-5Relevant academic research and scientific papers
TGF-betaR1 inhibitor and application thereof
-
Paragraph 0891; 0893-0895, (2020/06/09)
The invention belongs to the field of medical chemistry, and particularly relates to a compound serving as a TGF-betaR1 inhibitor and application of the compound. Specifically, the invention providesa compound shown as a formula I or an isomer, a pharmaceutically acceptable salt, a solvate, a crystal or a prodrug thereof, a preparation method of the compounds, a pharmaceutical composition containing the compounds and application of the compounds or the composition to treatment and/or prevention of TGF-betaR1 related diseases, such as cancers, tissue hyperplasia diseases, fibrosis and inflammatory diseases. The compound provided by the invention shows significant inhibitory activity on TGF-betaR1 kinase, and is very expected to become a therapeutic agent for TGF-betaR1 related diseases.
